Molecular Polymorphisms of Vascular Endothelial Growth Factor Gene and Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
02
2022
accepted:
02
08
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting primarily preterm and very low birth weight (VLBW) infants. Despite the advances in perinatal care, BPD remains a major clinical and costly complication in premature infants. The pathogenesis of BPD is complex and multifactorial. Prematurity, mechanical ventilation, oxidative stress, and inflammation are recognized as major interrelated contributing factors. Recently, some candidate genes involved in angiogenesis and alveolarization regulating mechanisms have been associated to BPD risk development. The aim of this study was to evaluate the role of vascular endothelial growth factor (VEGF) polymorphisms on BPD onset in VLBW newborns. Eighty-two VLBW infants, without major anomalies, were consecutively enrolled: 33 developed BPD (BPD group) and 49 infants without BPD served as controls (control group). In all infants, two polymorphisms, respectively (VEGF receptor) Significant statistic differences were found between BPD newborns and controls with regard to gestational age, birth weight, mechanical ventilation, duration of oxygen therapy, maternal preeclampsia, and chorioamnionitis. No differences were detected between genotypic and allelic levels regarding Two single nucleotide polymorphisms within
Sections du résumé
Background
UNASSIGNED
Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting primarily preterm and very low birth weight (VLBW) infants. Despite the advances in perinatal care, BPD remains a major clinical and costly complication in premature infants. The pathogenesis of BPD is complex and multifactorial. Prematurity, mechanical ventilation, oxidative stress, and inflammation are recognized as major interrelated contributing factors. Recently, some candidate genes involved in angiogenesis and alveolarization regulating mechanisms have been associated to BPD risk development. The aim of this study was to evaluate the role of vascular endothelial growth factor (VEGF) polymorphisms on BPD onset in VLBW newborns.
Methods
UNASSIGNED
Eighty-two VLBW infants, without major anomalies, were consecutively enrolled: 33 developed BPD (BPD group) and 49 infants without BPD served as controls (control group). In all infants, two polymorphisms, respectively (VEGF receptor)
Results
UNASSIGNED
Significant statistic differences were found between BPD newborns and controls with regard to gestational age, birth weight, mechanical ventilation, duration of oxygen therapy, maternal preeclampsia, and chorioamnionitis. No differences were detected between genotypic and allelic levels regarding
Conclusions
UNASSIGNED
Two single nucleotide polymorphisms within
Identifiants
pubmed: 36092960
doi: 10.1155/2022/2793846
pmc: PMC9458363
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2793846Informations de copyright
Copyright © 2022 Laura Filonzi et al.
Déclaration de conflit d'intérêts
The authors declared that there are no conflict of interest regarding the publication of this paper.
Références
Am J Physiol Lung Cell Mol Physiol. 2002 Sep;283(3):L555-62
pubmed: 12169575
J Reprod Immunol. 2011 Jan;88(1):53-7
pubmed: 20956022
Pediatrics. 1988 Oct;82(4):527-32
pubmed: 3174313
Dis Markers. 2010;29(1):1-9
pubmed: 20826912
J Pediatr. 2015 Mar;166(3):531-7.e13
pubmed: 25449221
Semin Neonatol. 2003 Feb;8(1):73-81
pubmed: 12667832
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004454
pubmed: 16856047
Arch Dis Child Fetal Neonatal Ed. 2012 Jan;97(1):F8-F17
pubmed: 21697236
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L344-51
pubmed: 15064225
Cancer Res. 2003 Feb 15;63(4):812-6
pubmed: 12591731
Respir Med. 2017 Nov;132:170-177
pubmed: 29229093
Breast Cancer Res Treat. 2012 Jun;133(2):769-78
pubmed: 22315135
Pediatrics. 2009 Sep;124(3):e450-8
pubmed: 19706590
Nat Genet. 2003 Aug;34(4):383-94
pubmed: 12847526
Circulation. 1996 Apr 15;93(8):1493-5
pubmed: 8608615
Diabetes. 2002 May;51(5):1635-9
pubmed: 11978667
Lancet. 2006 Apr 29;367(9520):1421-31
pubmed: 16650652
Fertil Steril. 2005 Apr;83(4):959-63
pubmed: 15820807
Pediatr Pulmonol. 2007 Oct;42(10):952-61
pubmed: 17726703
Ann Am Thorac Soc. 2014 Apr;11 Suppl 3:S146-53
pubmed: 24754823
Pediatr Res. 2008 Dec;64(6):682-8
pubmed: 18614962
JAMA. 2011 Dec 7;306(21):2348-58
pubmed: 22147379
Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L600-7
pubmed: 10956636
Semin Perinatol. 2013 Apr;37(2):85-93
pubmed: 23582962
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1429-33
pubmed: 10228106
Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L588-95
pubmed: 16679381
Pediatrics. 2010 Sep;126(3):443-56
pubmed: 20732945
Curr Opin Pediatr. 2011 Jun;23(3):305-13
pubmed: 21494147
PLoS One. 2013 Sep 20;8(9):e75168
pubmed: 24073247
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
Neonatology. 2017;111(4):367-375
pubmed: 28125815
Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L272-8
pubmed: 17575008